Plain-English translation of NCT04699864 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial evaluated whether a computer program called NeoRetina could accurately detect diabetic eye disease by analyzing photos of the back of the eye. The researchers compared results from this artificial intelligence tool with traditional eye exams performed by eye doctors to see if the technology could be used for early screening.
Diabetes-related eye disease is a major cause of blindness, and about 40% of people with diabetes develop it. However, there aren't enough eye doctors available to examine all diabetic patients regularly, so this treatment explores whether artificial intelligence could help identify who needs care.
Participants would have their eyes photographed and scanned using the artificial intelligence system, and then receive a standard eye exam by an ophthalmologist at the hospital. The study would compare how well each method detected diabetes-related eye disease. This was a diagnostic study, so participants were not receiving treatment but rather being evaluated.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Canada
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborators
DIAGNOS Inc.
Enrollment target
~24 participants
Started
June 2024
Primary completion
July 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.